Extension of the PRISMA 2020 statement for living systematic reviews (PRISMA-LSR): checklist and explanation
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 35 of the 44 sources its claims cite were checked for support.
Abstract
Publications of living systematic reviews (LSRs) are increasing rapidly. Guidance facilitating transparent, complete, and accurate reporting of LSRs is needed. This paper reports the development of an extension of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 statement for LSRs (PRISMA-LSR). The PRISMA-LSR extension includes the PRISMA-LSR checklist, the PRISMA-LSR flow diagram, reporting recommendations for the LSR status, and an explanation and elaboration document. This extension has been developed as an “add-on” to the PRISMA 2020 statement, meaning it should be used in addition to the PRISMA 2020 statement. The PRISMA-LSR extension is expected to benefit authors, editors, peer reviewers, and users of LSRs through transparent, complete, and accurate reporting of LSRs.
Overview
CoChat Summary
TL;DR
The PRISMA-LSR extension adapts the PRISMA 2020 statement for living systematic reviews (LSRs), adding four new checklist items and 29 LSR-specific elements to improve reporting of living mode parameters, changes to methods and results, and version-specific authorship. It also provides LSR status reporting recommendations and four tailored flow diagram templates.
Key findings
- The PRISMA-LSR checklist adds four new items: (L1) living mode parameters, (L2) changes to the methods, (L3) changes to the results, and (L4) authors and their roles for each version of the LSR.
- It adds 29 elements specific to LSR reporting and new elements under existing PRISMA 2020 items, including identification as “living” in the title, versioning, justification for living mode, retirement plans, and changes since the preceding version.
- Four LSR-tailored flow diagrams are proposed, with an R package and web-based ShinyApp to create PRISMA 2020 flow diagrams for each approach.
- The extension includes reporting recommendations for LSR status after the latest version, covering whether the review is ongoing or retired, new eligible studies, plans for the forthcoming version, and dates of last search/status update.
Methods
- A nine-person executive committee followed EQUATOR Network guidance for developing health research reporting guidelines, registered the project, obtained ethics approval, and sought written informed consent from survey participants.
- Development drew on four background studies: a methodological survey of flow diagram reporting in published LSRs, a concept paper on covid-19 LSR methodological challenges, a methodological survey of published LSRs, and a scoping review of methodological literature on LSRs.
- A first draft based on the expanded PRISMA 2020 checklist was reviewed by an international expert panel; 67 of 76 invited people (88%) accepted, participated in four initial online meetings in March-April 2022 and an online survey, and provided feedback on a second draft during seven online meetings in October-November 2022. The committee used 66% agreement as a guide for inclusion.
Limitations
- The paper states that the authors could not recruit consumers to be part of the study, though they plan to do so in future updates.
- The paper states that resource limitations required expert panel meetings to be online, and time zone differences prevented a single session for all panellists; the planned interview study exploring authors’ views and experiences was not completed because of time constraints.
- The paper states that the efficiency and effectiveness of integrated checklists need testing, and that more research is needed on best reporting practices for LSRs; it also notes major LSR challenges beyond reporting, including workload and publication platforms not being fit for purpose.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
23 Valid · 7 Not valid · 8 Not checked · 41 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For example, for some covid-19 related LSRs, authors initially included non-randomised studies, but later excluded these studies and included clinical trials. 19”
What the sources say
- Partly supportedcites [19] matched to “Methodological challenges for living systematic reviews conducted during the COVID-19 pandemic: A concept paper” (2022) sourceExperimental — accuracy not yet measured
In “Relevant design of studies? – a choice based on new conditions” (page unavailable), the paper says some COVID-19 LSRs included observational studies early because RCTs were scarce. It does not say those LSRs later excluded the observational studies and added clinical trials; for the authors’ own review, it instead describes a later decision to include additional safety data from controlled and uncontrolled studies. (LLM, conf=0.82)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, the reporting guidance is also applicable to LSRs with objectives other than evaluating effects of health interventions (eg, those evaluating diagnostic test accuracy, 23 prognostic factors, or prediction models).”
What the sources say
- Supportedcites [23] matched to “Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist” (2020) source
The citation is attached to the diagnostic-test-accuracy example. The Abstract identifies this paper as an explanation of PRISMA-DTA guidance for reporting systematic reviews of diagnostic test accuracy studies; the citing authors’ extension of their own guidance to living reviews is not attributed to this source. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Only one paper identified by that scoping review reported on the frequency of certainty of evidence assessment, which was after regular updating. 20”
What the sources say
- Supportedcites [20] matched to “Methods and guidance on conducting, reporting, publishing, and appraising living systematic reviews: a scoping review” (2023) source
The Results section’s LSR conducting guidance table lists the frequency of certainty-of-evidence assessment as reported by one of 17 papers and gives its guidance as “Regular updating.” This supports both the count and the stated frequency. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The extension has been developed for full reports of LSRs; therefore, authors and journals need to define which items and elements of the checklist apply to a partial report of their LSR”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“One of the likely reasons for these reporting issues is the absence of reporting guidance specific to the unique issues that arise in LSRs.”
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Probably not a substantial claim. 72
- It may state two separate claims as one. 25
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Several extensions of PRISMA for other types of evidence synthesis have since been established [14][15][16].”
From Updating the PRISMA reporting guideline for scoping reviews: a scoping review (2026) · cites this paper as [15]
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Self-citationPRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223 · cited 1×
“However, authors preparing a protocol for an LSR should, in addition to adhering to the PRISMA for Protocols (PRISMA-P) 2015 statement 24 (currently being updated), address specific PRISMA-LSR items.”
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-021-01626-4 · Cited by 13,874
Self-citationPage, M. J., Moher, D., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n160 · Cited by 13,262
Self-citationHutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P. A., Straus, S., Thorlund, K., Jansen, J. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2385 · Cited by 8,269
Rethlefsen, M. L., Kirtley, S., Waffenschmidt, S., Ayala, A. P., Moher, D., Page, M. J., Koffel, J. B., PRISMA-S Group, Blunt, H., Brigham, T., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-020-01542-z · Cited by 3,714 · cited 1×
“36 • Relating to PRISMA 2020 item 7: As understanding of the condition being studied and the evidence evolves, relevant terms, keywords, or database filters might change.”
Self-citationRethlefsen, M. L., Kirtley, S., Waffenschmidt, S., Ayala, A. P., Moher, D., Page, M. J., & Koffel, J. (2019) · doi:10.31219/osf.io/sfc38 · Cited by 3,696
Self-citationGuidance for Developers of Health Research Reporting Guidelines
Moher, D., Schulz, K. F., Simera, I., & Altman, D. G. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000217 · Cited by 1,437 · cited 1×
“We followed the EQUATOR Network’s guidance for developing health research reporting guidelines 17 and registered the project.”
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
Woodcock, J., & LaVange, L. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1510062 · Cited by 1,020 · cited 1×
“A specific example is platform trials (ie, “trials that study multiple targeted therapies in the context of a single disease in a perpetual manner, with therapies allowed to enter or leave the platform on the basis of a decision algorithm” 44”
Drug treatments for covid-19: living systematic review and network meta-analysis
Siemieniuk, R. A., Bartoszko, J. J., Zeraatkar, D., Kum, E., Qasim, A., Díaz Martinez, J. P., Izcovich, A., Rochwerg, B., Lamontagne, F., Han, M. A., et al. (2020) · BMJ · doi:10.1136/bmj.m2980 · Cited by 846
Page, M. J., & Moher, D. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0663-8 · Cited by 769
Self-citationSalameh, J.-P., Bossuyt, P. M., McGrath, T. A., Thombs, B. D., Hyde, C. J., Macaskill, P., Deeks, J. J., Leeflang, M., Korevaar, D. A., Whiting, P., et al. (2020) · BMJ · doi:10.1136/bmj.m2632 · Cited by 719
Living systematic review: 1. Introduction-the why, what, when, and how
Elliott, J. H., Synnot, A., Turner, T., Simmonds, M., Akl, E. A., McDonald, S., Salanti, G., Meerpohl, J., MacLehose, H., Hilton, J., et al. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.08.010 · Cited by 655
Self-citationLiving Systematic Reviews: An Emerging Opportunity to Narrow the Evidence-Practice Gap
Elliott, J. H., Turner, T., Clavisi, O., Thomas, J., Higgins, J. P. T., Mavergames, C., & Gruen, R. L. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001603 · Cited by 596
Hutton, B., Catalá-López, F., & Moher, D. (2016) · Medicina Clínica · doi:10.1016/j.medcli.2016.02.025 · Cited by 591 · cited 1×
“22 However, the reporting guidance is also applicable to LSRs with objectives other than evaluating effects of health interventions (eg, those evaluating diagnostic test accuracy, 23 prognostic factors, or prediction models).”
Publishing: Credit where credit is due
Allen, L., Scott, J., Brand, A., Hlava, M., & Altman, M. (2014) · Nature · doi:10.1038/508312a · Cited by 348
Farrah, K., Young, K., Tunis, M. C., & Zhao, L. (2019) · Systematic Reviews · doi:10.1186/s13643-019-1172-8 · Cited by 246
Santesso, N., Carrasco-Labra, A., Langendam, M., Brignardello-Petersen, R., Mustafa, R. A., Heus, P., Lasserson, T., Opiyo, N., Kunnamo, I., Sinclair, D., et al. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.12.006 · Cited by 173
Self-citationSexual transmission of Zika virus and other flaviviruses: A living systematic review
Counotte, M. J., Kim, C. R., Wang, J., Bernstein, K., Deal, C. D., Broutet, N. J. N., & Low, N. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002611 · Cited by 166 · cited 1×
“31”
Interventions for myopia control in children: a living systematic review and network meta-analysis
Lawrenson, J. G., Shah, R., Huntjens, B., Downie, L. E., Virgili, G., Dhakal, R., Verkicharla, P. K., Li, D., Mavi, S., Kernohan, A., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014758.pub2 · Cited by 164
Kambhampati, S. B. S., Vaishya, R., & Vaish, A. (2020) · Journal of Clinical Orthopaedics and Trauma · doi:10.1016/j.jcot.2020.04.030 · Cited by 133
Prophylaxis against covid-19: living systematic review and network meta-analysis
Bartoszko, J. J., Siemieniuk, R. A., Kum, E., Qasim, A., Zeraatkar, D., Martinez, J. P. D., Azab, M., Ibrahim, S., Izcovich, A., Soto, G. B., et al. (2021) · BMJ · doi:10.1136/bmj.n949 · Cited by 113 · cited 1×
“43”
Thoracic imaging tests for the diagnosis of COVID-19
Ebrahimzadeh, S., Islam, N., Dawit, H., Salameh, J., Kazi, S., Fabiano, N., Treanor, L. M., Absi, M., Ahmad, F., Rooprai, P., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013639.pub5 · Cited by 96
(2022) · doi:10.1371/journal.pmed.1003987 · Cited by 81
Siemieniuk, R. A., Bartoszko, J. J., Díaz Martinez, J. P., Kum, E., Qasim, A., Zeraatkar, D., Izcovich, A., Mangala, S., Ge, L., Han, M. A., et al. (2021) · BMJ · doi:10.1136/bmj.n2231 · Cited by 79
Wilt, T. J., Kaka, A. S., MacDonald, R. H., Greer, N. L., Obley, A. J., & Duan‐Porter, W. (2020) · Annals of Internal Medicine · doi:10.7326/m20-5752 · Cited by 77 · cited 1×
“• “We plan to update our literature search … every 2 months through December 2021 …” 34 • “Each year, we will consider the necessity for the review to be a living systematic review by assessing ongoing relevance of the question to decision-makers and by determining whether uncertainty is ongoing in…”
Convalescent plasma for people with COVID-19: a living systematic review
Iannizzi, C., Chai, K. L., Piechotta, V., Valk, S. J., Kimber, C., Monsef, I., Wood, E. M., Lamikanra, A., Roberts, D. J., McQuilten, Z., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013600.pub5 · Cited by 68
Self-citationConvalescent plasma for people with COVID-19: a living systematic review
Iannizzi, C., Chai, K. L., Piechotta, V., Valk, S. J., Kimber, C., Monsef, I., Wood, E. M., Lamikanra, A., Roberts, D. J., McQuilten, Z., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013600.pub6 · Cited by 60
Self-citationKaka, A. S., MacDonald, R. H., Linskens, E. J., Langsetmo, L., Vela, K., Duan‐Porter, W., & Wilt, T. J. (2022) · Annals of Internal Medicine · doi:10.7326/m21-4784 · Cited by 56 · cited 1×
“41”
Past, present and future of living systematic review: a bibliometrics analysis
Zheng, Q., Xu, J., Gao, Y., Liu, M., Cheng, L., Xiong, L., Cheng, J., Yuan, M., OuYang, G., Huang, H., et al. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2022-009378 · Cited by 51
Kahale, L. A., Elkhoury, R., El Mikati, I., Pardo-Hernandez, H., Khamis, A. M., Schünemann, H. J., Haddaway, N. R., & Akl, E. A. (2022) · F1000Research · doi:10.12688/f1000research.51723.3 · Cited by 48
Self-citationNirmatrelvir combined with ritonavir for preventing and treating COVID-19
Reis, S., Metzendorf, M., Kuehn, R., Popp, M., Gágyor, I., Kranke, P., Meybohm, P., Skoetz, N., & Weibel, S. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015395.pub3 · Cited by 47
Self-citationUpdate Alert: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19
Hernandez, A. V., Roman, Y. M., Pasupuleti, V., Barboza, J. J., & White, C. M. (2020) · Annals of Internal Medicine · doi:10.7326/l20-0945 · Cited by 46
Iannizzi, C., Dorando, E., Burns, J., Weibel, S., Dooley, C., Wakeford, H., Estcourt, L. J., Skoetz, N., & Piechotta, V. (2022) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.09.013 · Cited by 45
Self-citationDevane, D., Burke, N. N., Treweek, S., Clarke, M., Thomas, J., Booth, A., Tricco, A. C., & Saif‐Ur‐Rahman, K. M. (2022) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12505 · Cited by 39
Methods for developing and reporting living evidence synthesis
Bendersky, J., Auladell-Rispau, A., Urrútia, G., & Rojas, M. X. (2022) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2022.09.020 · Cited by 34
Schmidt, L., Sinyor, M., Webb, R. T., Marshall, C., Knipe, D., Eyles, E. C., John, A., Gunnell, D., & Higgins, J. P. T. (2023) · Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen · doi:10.1016/j.zefq.2023.06.007 · Cited by 31 · cited 1×
“We did not address the use of artificial intelligence in PRISMA-LSR because it is not restricted to LSRs. 25 26”
Kansagara, D. L., Mackey, K., & Vela, K. (2020) · Annals of Internal Medicine · doi:10.7326/l20-0887 · Cited by 31
Iannizzi, C., Akl, E. A., Anslinger, E., Weibel, S., Kahale, L. A., Aminat, A. M., Piechotta, V., & Skoetz, N. (2023) · Systematic Reviews · doi:10.1186/s13643-023-02396-x · Cited by 31 · cited 14×
“21 The discussion was informed by the findings of the background studies and members’ experience undertaking LSRs.”
InfluentialSelf-citationPage, M. J., Moher, D., Brennan, S., & McKenzie, J. E. (2023) · Systematic Reviews · doi:10.1186/s13643-023-02363-6 · Cited by 31 · cited 1×
“28 Nonetheless, the efficiency of such integrated checklists and their effectiveness at improving reporting would need to be tested.”
Self-citationHow to update a living systematic review and keep it alive during a pandemic: a practical guide
Heron, L., Buitrago-Garcia, D., Ipekci, A. M., Baumann, R., Imeri, H., Salanti, G., Counotte, M. J., & Low, N. (2023) · Systematic Reviews · doi:10.1186/s13643-023-02325-y · Cited by 26 · cited 7×
“Furthermore, they could ensure easy access to the most recent version of the LSR, earlier versions, and track changes between versions.”
InfluentialExtension of the PRISMA 2020 statement for living systematic reviews (LSRs): protocol
Kahale, L. A., Piechotta, V., McKenzie, J. E., Dorando, E., Iannizzi, C., Barker, J. M., Page, M. J., Skoetz, N., & Akl, E. A. (2022) · F1000Research · doi:10.12688/f1000research.75449.1 · Cited by 24 · cited 14×
“21 The discussion was informed by the findings of the background studies and members’ experience undertaking LSRs.”
InfluentialSelf-citationThe life and death of living systematic reviews: a methodological survey
Akl, E. A., El Khoury, R., Khamis, A. M., El Mikati, I. K., Pardo-Hernandez, H., Farran, S., Ibrahim, R., Khamis, M., Hneiny, L., Schunemann, H. J., et al. (2023) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2023.02.005 · Cited by 21 · cited 3×
“…13 ; a concept paper on methodological challenges with covid-19 reviews that were described as LSRs 19 ; a methodological survey of published LSRs 14 ; and a scoping review of the methodological literature on LSRs. 20 Because of time constraints, we did not complete the planned interview study…”
InfluentialSelf-citationFrom standard systematic reviews to living systematic reviews
Breuer, C., Meerpohl, J. J., & Siemens, W. (2023) · Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen · doi:10.1016/j.zefq.2022.11.007 · Cited by 21
Living systematic review: new inputs and challenges
Vergara-Merino, L., Verdejo, C., Carrasco, C., & Vargas-Peirano, M. (2020) · Medwave · doi:10.5867/medwave.2020.11.8092 · Cited by 18 · cited 12×
“21 The discussion was informed by the findings of the background studies and members’ experience undertaking LSRs.”
InfluentialProposed triggers for retiring a living systematic review
Murad, M. H., Wang, Z., Chu, H., Lin, L., El Mikati, I. K., Khabsa, J., Akl, E. A., Nieuwlaat, R., Schuenemann, H. J., & Riaz, I. B. (2023) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2022-112100 · Cited by 17 · cited 1×
“…conclusive, which can be determined based on certainty of the evidence or statistical methods; when the topic becomes less relevant to stakeholders; when new studies are not expected to be published; when required resources become unavailable 33 ; however, other triggers might also be possible.”
Self-citationMetzendorf, M., Weibel, S., Reis, S., & McDonald, S. J. (2022) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2022-112019 · Cited by 10
Interventions for the treatment of COVID-19: a living network meta-analysis
Boutron, I., Chaimani, A., Devane, D., Meerpohl, J. J., Rada, G., Hróbjartsson, A., Tovey, D. I., Grasselli, G., & Ravaud, P. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013770 · Cited by 9 · cited 1×
“32”
Conceptualizing the reporting of living systematic reviews
Khabsa, J., Chang, S., McKenzie, J. E., Barker, J. M., Boutron, I., Kahale, L. A., Page, M. J., Skoetz, N., & Akl, E. A. (2023) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2023.01.008 · Cited by 8 · cited 1×
“21 The discussion was informed by the findings of the background studies and members’ experience undertaking LSRs.”
Self-citationlivingPRISMAflow: R package and ShinyApp for producing living PRISMA flow diagrams
Haddaway, N. R. (2021) · Zenodo · doi:10.5281/zenodo.4572459 · Cited by 1
livingPRISMAflow: R package and ShinyApp for producing living PRISMA flow diagrams
Haddaway, N. R. (2021) · Figshare · doi:10.5281/zenodo.4572458 · Cited by 1
Research works printed but not linked: 1
- F1000Research. Article Guidelines (New Versions). Available from: https://f1000research.com/for-authors/article-guidelines-new-versions.
Cited by
Bas, T. G. (2025) · Pharmaceuticals · doi:10.3390/ph18060908 · Cited by 33
Vosoughi, F., Vahedi, P., Nakhjiri, M. T., Keyhani, S., Soleymanha, M., LaPrade, R. F., Tollefson, L. V., & Oskouie, I. M. (2025) · Knee Surgery Sports Traumatology Arthroscopy · doi:10.1002/ksa.12796 · Cited by 17
Chin, C. P., Alias, A., & Alkharabsheh, O. H. M. (2025) · Discover Sustainability · doi:10.1007/s43621-025-01923-1 · Cited by 23
Zeraatkar, D., Ling, M., Kirsh, S., Jassal, T., Pitre, T., Chakraborty, S. P., Turner, T., Turkstra, L. S., McIntyre, R. S., Izcovich, A., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-086407 · Cited by 18
Prabhakornritta, P., Waranuch, N., Fuangchan, A., Srikham, K., Boonpattharatthiti, K., Barnig, C., Boonyasuppayakorn, S., Pitaksuteepong, T., Bhattarakosol, P., Moulari, B., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1598255 · Cited by 11
Metadata
- Authors
- Akl, E. A., Khabsa, J., Iannizzi, C., Piechotta, V., Kahale, L. A., Barker, J. M., McKenzie, J. E., Page, M. J., & Skoetz, N.
- Affiliations
- McMaster University (CA)
- American University of Beirut Medical Center (LB)
- University of Cologne (DE)
- Robert Koch Institute (DE)
- Infectious Diseases Society of America (US)
- Faculty of 1000 (United Kingdom) (GB)
- Monash University (AU)
- Corresponding author
- Akl, Elie A
- ORCID
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2024-11-19
- Volume
- 387
- Pages
- e079183
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W4404517784
- Cited by
- 103
- References
- 51
- Citations by year
- 2026: 76 · 2025: 27
- FWCI
- 8.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BMJ (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
- Keywords
- living systematic review, reporting guidelines, reporting checklist, PRISMA flow diagram, reporting transparency, systematic review methodology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.